The acellular dermal matrices are used in various soft tissue reconstruction procedures such as breast reconstruction after mastectomy. Acellular dermal matrices are used as an adjunct to implant-based breast reconstruction to form an implant pocket and improve lower pole fullness. The global demand for breast reconstruction procedures is consistently rising owing to the increasing prevalence of breast cancer worldwide. According to the Centers for Disease Control and Prevention, about 276,480 new cases of invasive breast cancer were diagnosed in the U.S. in 2020. Acellular dermal matrices play a vital role in tissue reconstruction and pocket formation during implant-based breast reconstruction procedures for women undergoing mastectomy.
The U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2,783.32 million in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growing adoption of soft tissue reconstruction procedures is expected to propel the growth of the U.S. acellular dermal matrices market over the forecast period. The rising prevalence of breast cancer in the U.S. has increased the number of mastectomies and breast reconstruction procedures performed annually. According to the American Society of Plastic Surgeons, over 155,000 breast reconstruction procedures were performed in the U.S. in 2020 alone. Acellular dermal matrices are widely used in implant-based breast reconstruction to prevent capsular contracture and achieve better aesthetic outcomes.
Another driver for the market growth is increasing research and development activities focused on developing advanced acellular dermal matrices. Key players are engaged in developing matrices with improved absorption and integration capabilities to achieve optimal reconstructive outcomes. For instance, in July 2019, MTF Biologics received approval from the FDA for use of AlloDerm Regenerative Tissue Matrix in abdominal wall reconstruction. Such product approvals and launches are expected to further support the market growth over the forecast period.
Segment Analysis
The U.S. acellular dermal matrices market is currently dominated by the breast reconstruction segment. It holds the largest market share owing to the rising number of breast cancer-related surgeries in the United States. Acellular dermal matrices are extensively used in breast reconstructions after mastectomies to form a new breast mound and substitute for tissue expended during cancer removal.
PEST Analysis
Political: The U.S. acellular dermal matrices market is regulated by organizations like the U.S. Food and Drug Administration (FDA). Any changes in regulations regarding the production, approval, and clinical use of tissue products can impact the market.
Economic: The rising disposable incomes and enhanced healthcare expenditure have increased the demand for acellular dermal matrices for various reconstructive procedures in the country over the past few years.
Social: The increasing incidence of breast cancer in women, trauma cases, and accidental injuries along with rising awareness about reconstructive surgeries are some key social factors spurring the demand for acellular dermal matrices in the country.
Technological: Technological advancements in acellular dermal matrix products to enhance clinical properties like ease of handling, shelf life, and biocompatibility have widened their application scope in various surgical specialties like urology, gynecology, and general surgery.
Key Takeaways
The U.S. Acellular Dermal Matrices Market Size is expected to witness high growth. The U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2,783.32 million in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.
The U.S. market holds the dominant share of the global market and is expected to maintain its lead over the forecast period due to increasing breast cancer incidence rates as well as raising awareness regarding reconstructive procedures.
Key players operating in the U.S. acellular dermal matrices market are LifeCell Corporation, MTF Biologics, Integra LifeSciences Corporation, Stryker Corporation, OSSTEM IMPLANT Co.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
